Avita Medical | 1811094D - Debt



Avita Medical reported AUD45.98M in Debt for its fiscal semester ending in December of 2024.


Debt Change Date
Adcock Ingram Holdings ZAR 969.4M 688.86M Dec/2024
Celltrion KRW 2.22T 24.87B Mar/2025
Clinuvel Pharmaceuticals AUD 879.78K 189.09K Jun/2024
Cochlear AUD 246.6M 2.9M Dec/2024
CSL USD 11.96B 219M Dec/2024
Cspc Pharmaceutical CNY 507.33M 118.46M Dec/2024
Dianthus Therapeutics USD 1.33M 161K Jun/2025
Divis Laboratories Ltd 40M 40M Mar/2025
Kangmei Pharma CNY 221.82M 958.68M Mar/2025
Knight Therapeutics CAD 58.22M 109K Sep/2024
Laboratorios Farma EUR 129.3M 14.89M Jun/2025
Malin Corporation EUR 0 0 Dec/2024
Mayne Pharma AUD 38.82M 2.24M Jun/2024
Medical Developments International AUD 2.14M 144K Dec/2024
Nanosonics AUD 9.17M 130K Dec/2024
Neuren Pharmaceuticals AUD 0 0 Dec/2024
Organigram Holdings CAD 9.15M 35.6M Jun/2025
Pacific Edge NZD 2.9M 425K Mar/2025
Paradigm Biopharmaceuticals AUD 181.4K 38.99K Dec/2024
Pharma Mar EUR 51.4M 405K Jun/2025
Polynovo AUD 15.38M 49K Jun/2024
PYC Therapeutics AUD 1.21M 96.02K Dec/2024
Qiagen NV USD 1.44B 35.7M Jun/2025
Ramsay Health Care AUD 11.26B 317.4M Dec/2024
ResMed USD 851.81M 179.05M Jun/2025
Sartorius EUR 4.66B 25.7M Jun/2025
Sino Biopharmaceutical CNY 9.71B 33.98M Dec/2024
Telix Pharmaceuticals AUD 581.45M 559.3M Dec/2024
Tilray USD 351.72M 15.26M Nov/2024
Zz Pientze Pharmaceu 1.12B 70.31M Mar/2025